Luis Margusino-Framiñán

10PUBLICATIONS
30CO-AUTHORS
Software quality, processes and metricsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyCancer therapy (excl. chemotherapy and radiation therapy)Patient safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 06, 2026
Practical guide for the selection of digital solutions oriented to PROMs and PREMs in the hospital pharmacy.

|Mar 19, 2026
Intravenous non-specific immunoglobulins as adjunctive therapy for invasive Streptococcus pyogenes infection: an eleven-year retrospective study.

Laura Caeiro-Martínez, David Brandariz-Núñez, María Sandra Albiñana-Pérez

|Feb 13, 2026
Role of biological therapies targeting eosinophils in eosinophilic granulomatosis with polyangiitis: current evidence and future perspectives.

Rosa Rodríguez-Mauriz, María Nélida Fernández-Martínez, Marta Calvin-Lamas

|May 25, 2025
Real-World Safety Profile of Ibrutinib in Chronic Lymphocytic Leukemia: A Focus on Adverse Events, Discontinuations, and Effectiveness Outcomes.

Alejandro Martínez Pradeda, Pablo Feijoo Vilanova, Elena Fernández Gabriel

|May 13, 2025
Validation of a Scorecard of Quality and Activity Indicators for Telepharmacy Pharmaceutical Care Services in Spanish Hospitals.

Luis Margusino-Framiñán, Olatz Ibarra-Barrueta, Irene Mangues-Bafalluy

|Feb 26, 2025
Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study.

Teresa Calleja-Chucla, Patricia Cordeiro González, Alejandro Martínez Pradeda

Pageof 2

Frequent Collaborators

3 joint publications

Ramón Morillo-Verdugo

2 joint publications

Alejandro Martínez Pradeda

1 joint publications

Alvaro Mena

1 joint publications

Luis Morano